PTC Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
PTC Therapeutics (NASDAQ: PTCT) has announced that its CEO, Matthew B. Klein, M.D., will deliver a presentation at the 43rd Annual J.P.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
PTC Therapeutics (NASDAQ: PTCT) has announced that its CEO, Matthew B. Klein, M.D., will deliver a presentation at the 43rd Annual J.P. Morgan Healthcare Conference. The presentation is scheduled for Monday, January 13, 2025, at 11:15 a.m. PST / 2:15 p.m. EST.
The event will be accessible via webcast on PTC Therapeutics' website under the Investors section's Events and Presentations page. Viewers can access the webcast at https://ir.ptcbio.com/events-presentations, and the recording will remain available for 30 days after the presentation. Attendees are advised to connect several minutes before the start time to ensure proper connection.
Details
News Market Reaction – PTCT
The recorded move for PTCT in the trading session of this news was -1.47%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
The presentation will be webcast live on the Events and Presentations page under the Investors section of PTC Therapeutics' website at https://ir.ptcbio.com/events-presentations and will be archived for 30 days following the presentation. It is recommended that users connect to PTC's website several minutes prior to the start of the webcast to ensure a timely connection.
About PTC Therapeutics, Inc.
PTC is a global biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. PTC's ability to innovate to identify new therapies and to globally commercialize products is the foundation that drives investment in a robust and diversified pipeline of transformative medicines. To learn more about PTC, please visit us at www.ptcbio.com and follow us on Facebook, Instagram, LinkedIn and X.
For More Information:
Investors:
Ellen Cavaleri
+1 (615) 618-6228
ecavaleri@ptcbio.com
Media:
Jeanine Clemente
+1 (908) 912-9406
jclemente@ptcbio.com
View original content:https://www.prnewswire.com/news-releases/ptc-therapeutics-to-present-at-the-43rd-annual-jp-morgan-healthcare-conference-302338079.html
SOURCE PTC Therapeutics, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.